BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 30128871)

  • 1. Artificial Cycle with or without a Depot Gonadotropin-releasing Hormone Agonist for Frozen-thawed Embryo Transfer: An Assessment of Infertility Type that Is Most Suitable.
    Xie D; Chen F; Xie SZ; Chen ZL; Tuo P; Zhou R; Zhang J
    Curr Med Sci; 2018 Aug; 38(4):626-631. PubMed ID: 30128871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gonadotropin-releasing hormone agonist downregulation combined with hormone replacement therapy improves the reproductive outcome in frozen-thawed embryo transfer cycles for patients of advanced reproductive age with idiopathic recurrent implantation failure.
    Pan D; Yang J; Zhang N; Wang L; Li N; Shi J; Zhou H
    Reprod Biol Endocrinol; 2022 Feb; 20(1):26. PubMed ID: 35115007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols.
    Toftager M; Bogstad J; Løssl K; Prætorius L; Zedeler A; Bryndorf T; Nilas L; Pinborg A
    Hum Reprod; 2017 Mar; 32(3):556-567. PubMed ID: 28130435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A GnRH agonist and exogenous hormone stimulation protocol has a higher live-birth rate than a natural endogenous hormone protocol for frozen-thawed blastocyst-stage embryo transfer cycles: an analysis of 1391 cycles.
    Hill MJ; Miller KA; Frattarelli JL
    Fertil Steril; 2010 Feb; 93(2):416-22. PubMed ID: 19171338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using gonadotropin-releasing hormone agonist before frozen embryo transfer may improve ongoing pregnancy rates in hyperandrogenic polycystic ovary syndrome women.
    Tsai HW; Wang PH; Lin LT; Chen SN; Tsui KH
    Gynecol Endocrinol; 2017 Sep; 33(9):686-689. PubMed ID: 28393637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fertility outcomes in women after controlled ovarian stimulation with gonadotropin releasing hormone agonist long protocol: fresh versus frozen embryo transfer.
    Ding X; Yang J; Li L; Yang N; Lan L; Huang G; Ye H
    BMC Pregnancy Childbirth; 2021 Mar; 21(1):207. PubMed ID: 33711956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gonadotropin-releasing hormone agonist combined with hormone replacement therapy does not improve the reproductive outcomes of frozen-thawed embryo transfer cycle in elderly patients: a retrospective study.
    Dong M; Sun L; Huang L; Yi Y; Zhang X; Tan Y; Song G; Liu L; Wei F; Liu F
    Reprod Biol Endocrinol; 2020 Jul; 18(1):73. PubMed ID: 32669123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Live birth after frozen-thawed embryo transfer: which endometrial preparation protocol is better?
    Sahin G; Acet F; Calimlioglu N; Meseri R; Tavmergen Goker EN; Tavmergen E
    J Gynecol Obstet Hum Reprod; 2020 Oct; 49(8):101782. PubMed ID: 32360633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the adequacy of gonadotropin-releasing hormone agonist leuprolide to trigger oocyte maturation and management of inadequate response.
    Chang FE; Beall SA; Cox JM; Richter KS; DeCherney AH; Levy MJ
    Fertil Steril; 2016 Oct; 106(5):1093-1100.e3. PubMed ID: 27341988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of GnRH agonist and letrozole treatment in women with recurrent implantation failure.
    Steiner N; Shrem G; Tannus S; Dahan SY; Balayla J; Volodarsky-Perel A; Tan SL; Dahan MH
    Fertil Steril; 2019 Jul; 112(1):98-104. PubMed ID: 31133384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated doses of GnRH antagonist at midcycle in artificial frozen embryo transfer cycles may not affect pregnancy outcomes.
    Palmerola KL; Hsu JY; Grossman LC; Sauer MV; Lobo RA
    Gynecol Endocrinol; 2017 Apr; 33(4):301-305. PubMed ID: 28010150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endometrial preparation for vitrified-warmed embryo transfer with or without GnRH-agonist pre-treatment in patients with polycystic ovary syndrome: a randomized controlled trial.
    Salemi S; Yahyaei A; Vesali S; Ghaffari F
    Reprod Biomed Online; 2021 Sep; 43(3):446-452. PubMed ID: 34340936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of HCG-day serum progesterone and oestradiol concentrations on pregnancy outcomes in GnRH agonist cycles.
    Wu Z; Li R; Ma Y; Deng B; Zhang X; Meng Y; Chen X; Liu P; Qiao J
    Reprod Biomed Online; 2012 May; 24(5):511-20. PubMed ID: 22417667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does oral contraceptives pretreatment affect the pregnancy outcome in polycystic ovary syndrome women undergoing ART with GnRH agonist protocol?
    Xu Z; Meng L; Pan C; Chen X; Huang X; Yang H
    Gynecol Endocrinol; 2019 Feb; 35(2):124-127. PubMed ID: 30303700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is the effect of premature elevated progesterone augmented by human chorionic gonadotropin versus gonadotropin-releasing hormone agonist trigger?
    Connell MT; Patounakis G; Healy MW; DeCherney AH; Devine K; Widra E; Levy MJ; Hill MJ
    Fertil Steril; 2016 Sep; 106(3):584-589.e1. PubMed ID: 27178228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triggering of final oocyte maturation with gonadotropin-releasing hormone agonist or human chorionic gonadotropin. Live birth after frozen-thawed embryo replacement cycles.
    Griesinger G; Kolibianakis EM; Papanikolaou EG; Diedrich K; Van Steirteghem A; Devroey P; Ejdrup Bredkjaer H; Humaidan P
    Fertil Steril; 2007 Sep; 88(3):616-21. PubMed ID: 17451691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy outcomes after controlled ovarian hyperstimulation in women with endometriosis-associated infertility: GnRH-agonist versus GnRH-antagonist.
    Kolanska K; Cohen J; Bendifallah S; Selleret L; Antoine JM; Chabbert-Buffet N; Darai E; d'Argent EM
    J Gynecol Obstet Hum Reprod; 2017 Nov; 46(9):681-686. PubMed ID: 28970135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment with a long-acting GnRH agonist for frozen-thawed embryo transfer cycles: how to improve live birth?
    Xu B; Hou Z; Liu N; Zhao J; Li Y
    J Ovarian Res; 2023 Sep; 16(1):197. PubMed ID: 37743479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study.
    Engmann L; DiLuigi A; Schmidt D; Nulsen J; Maier D; Benadiva C
    Fertil Steril; 2008 Jan; 89(1):84-91. PubMed ID: 17462639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fresh versus frozen-thawed blastocyst transfer in high responders.
    Kalem Z; Namli Kalem M; Ruso H; Bakirarar B; Gurgan T
    Ginekol Pol; 2018; 89(8):407-413. PubMed ID: 30215458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.